Vascular-Targeted Photodynamic Therapy for Localized Prostate Cancer, NYU Langone Medical Center Study

ScienceDaily (July 27, 2010) — NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.

Back to news